Sagimet Biosciences Inc - Ordinary Shares - Class A Live Stock Price Today, Share Analysis and Chart

Name: Sagimet Biosciences Inc - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: Sagimet Biosciences Inc - Ordinary Shares - Class A
Rating: 1.78000
Author: Trendlyne DVM scores

about

Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolis...

6.92 -0.42 (-5.72%)

39.35% Fall from 52W High

317.5K

XNAS Volume

XNAS 29 Sep, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

10.5 / 100

Technically Moderately Bullish

60.7 / 100

1Yr Price target upside is 341%

8 analysts

Sagimet Biosciences Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Sagimet Biosciences Inc - Ordinary Shares - Class A Live Stock Price Today, Share Analysis and Chart

Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolis...

39.35% Fall from 52W High

SWOT Analysis

Sagimet Biosciences Inc Live Price Chart